Try Alerts Free   |   Login
Health Care › Surgical & Medical Instruments & Apparatus

PRCT Price Correlated With Financials For PROCEPT BioRobotics

Free historical financial statements for PROCEPT BioRobotics Corp.. See how revenue, income, cash flow, and balance sheet financials have changed over 3 quarters since 2021. Compare with PRCT stock chart to see long term trends.

PRCT Stock Compared to Quarterly

PRCT Income Statement

Revenue, Net:14197000
Revenue Per Share:0.3214
Cost of Goods & Services Sold:6505000
Gross Profit:7692000
Selling, General & Admin Expense:18385000
Research & Development Expense:5011000
Total Operating Expenses:23396000
Operating Income:-15704000
Net Income:-17185000
Earnings Per Share, Basic:-0.39
Shares Outstanding, Basic Avg:44173322

PRCT Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:758000
Change in Accounts Receiveable:2529000
Net Cash from Operations:-18231000
Net Cash from Operations Per Share:-0.4127
Net Cash from Financing Activities:1291000
Property, Plant & Equipment Purchases:55000
Net Cash from Investing Activities:-55000
Net Change in Cash & Equivalents:-16995000

PRCT Balance Sheet

Cash and Cash Equivalents:288102000
Accounts Receivable, Net:6992000
Inventories:12629000
Total Current Assets:307979000
Property, Plant & Equipment, Net:4560000
Total Assets:320912000
Accounts Payable:2628000
Current Portion of Long-Term Debt:0
Total Short-Term Liabilities:14757000
Long Term Debt, Non-Current Portion:50254000
Total Liabilities:68162000

Insider Trading

 
Change
Value
Transaction
SEC Form 4
Wood Morgan Colby   Director
940 sh at $24
$22,961
Buy

Data imported from PROCEPT BioRobotics Corp. SEC filings. Check original filings before making any investment decision.